Proteomics biomarkers for solid tumors: Current status and future prospects.

Belczacka, Iwona; Latosinska, Agnieszka; Metzger, Jochen; Marx, David; Vlahou, Antonia; Mischak, Harald; Frantzi, Maria

Belczacka, Iwona; Latosinska, Agnieszka; Metzger, Jochen; Marx, David; Vlahou, Antonia; Mischak, Harald; Frantzi, Maria.

Afiliação

Belczacka I; Mosaiques-Diagnostics GmbH, Hannover, Germany.
Latosinska A; University Hospital RWTH Aachen, Institute for Molecular Cardiovascular Research (IMCAR), Aachen, Germany.
Metzger J; Mosaiques-Diagnostics GmbH, Hannover, Germany.
Marx D; Mosaiques-Diagnostics GmbH, Hannover, Germany.
Vlahou A; Hôpitaux Universitaires de Strasbourg, Service de Transplantation Rénale, Strasbourg, France.
Mischak H; Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), University of Strasbourg, National Center for Scientific Research (CNRS), Institut Pluridisciplinaire Hubert Curien (IPHC) UMR 7178, Strasbourg, France.
Frantzi M; Biotechnology Division, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece.

Mass Spectrom Rev ; 38(1): 49-78, 2019 01.

Article em En | MEDLINE | ID: mdl-29889308

Assuntos

Neoplasias/diagnóstico; Proteínas/análise; Proteômica/métodos; Animais; Biomarcadores Tumorais/análise; Humanos; Espectrometria de Massas/métodos; Prognóstico

Palavras-chave

cancer; clinical proteomics; diagnosis; protein biomarkers; solid tumors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Proteômica / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Animals / Humans Idioma: En Revista: Mass Spectrom Rev Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google